The treatment planning for patients with hepatocellular carcinoma (HCC) relies
predominantly on tumor burden, clinical performance, and liver function test results. Curative …

The incidence of hepatocellular carcinoma continues to increase worldwide. Fortunately,
there have been notable recent advances in locoregional and systemic therapy. In this …

The role of the interventional radiologist (IR) in providing locoregional therapies for
hepatocellular carcinoma (HCC), has grown substantially in the last 30 years, and especially …

OBJECTIVE. This article focuses on imaging techniques and imaging findings after
locoregional and systemic therapy in patients with hepatocellular carcinoma (HCC). We …

Hepatocellular carcinoma (HCC) is one of the most frequent and deadliest cancers
worldwide. Liver transplantation, surgical resection or local ablation offer the best survival …

Early-stage hepatocellular carcinoma (HCC) is typically clinically silent, and HCC is often
advanced at first manifestation. Without treatment, the 5-year survival rate is less than 5 …

Locoregional techniques have become the mainstay of therapy for patients with
unresectable hepatocellular carcinoma (HCC). Such image-guided interventions include …

Abstract Purpose of Review: The high mortality rate for hepatocellular carcinoma (HCC)
relative to its prevalence underscores the need for curative-intent therapies. Image-guided …

Nearly 80% of cirrhotic patients diagnosed with hepatocellular carcinoma (HCC) are not
eligible for surgical resection and instead undergo local-regional treatment. After therapy for …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality
and the only cancer for which the incidence and mortality are on the rise. Sensitive and …